ghk cu safety studies Frontiers GHK-Cu 50mg, 100mg Research Compound

p53 tumour-suppressor caution Because FOXO4-DRI intervenes in the p53 pathway, which is critical for tumour suppression, there is theoretical concern that interfering with p53 dynamics might carry oncogenic risk

This suggests a reduced activation of the NF-B pathway, which drives the expression of many inflammatory genes

Its a gut peptide

Sign up for Dr

The interest is justified: the clinical evidence behind GHK-Cu is among the strongest of any peptide available, and its benefits are particularly relevant to the specific concerns men prioritize

If you are considering using AOD 9604, retatrutide, or any combination of unlicensed peptides for weight management or body composition purposes, it is strongly advisable to speak with a qualified healthcare professional before doing so